TTUHSC investigator evaluates the potential of neurolysin as

Ischemic stroke, the second leading cause of death worldwide, occurs when a vessel to the brain is blocked, reducing blood flow to the brain and depriving it of critical supplies of oxygen and nutrients.

Related Keywords

Delaney Farris Srinidhi Jayaraman , Andrew Baez , Thomasj Abbruscato , Paulc Trippier , Saeideh Nozohouri , Shafikur Rahman , Vardan Karamyan , Joanna Kocot , David Ostrov , Emily Henderson , Nihar Kinarivala , Shikha Kumari , Jerryh Hodge School Of Pharmacy , University Of Nebraska Medical Center , National Institutes Of Health , University Of Florida , Texas Tech University Health Sciences Center , Shiva Hadi Esfahani , Delaney Farris , Srinidhi Jayaraman , Nebraska Medical , National Institutes , Two Structurally Related Dipeptides , Enhance Catalytic Efficiency , Experimental Therapeutics , Brain , Flood , Drugs , Histidine , Ischemic Stroke , Medicinal Chemistry , Olecule , Nutrients , Oxygen , Eptides , Mh , Pharmacy , Research , Stroke , Herapeutics ,